New drug slashes death rates among drug-resistant TB patients –scientists

Google+ Pinterest LinkedIn Tumblr
Spread the love
A new treatment for a deadly drug-resistant strain of tuberculosis can cure more than 90 per cent of sufferers, according to a landmark clinical trial whose results were revealed exclusively to AFP.

Doctors in Belarus — a country with one of the world’s highest rates of multidrug-resistant tuberculosis — treated patients with the new drug, bedaquiline, in combination with other antibiotics.

Ninety-three per cent were cured, compared to just over half of cases treated with existing drugs, according to the study results.

Source: AFP


Write A Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.